SFX Entertainment, Inc. ( NASDAQ:SFXE ) (“SFX”) announced
today that it commenced a solicitation of consents (the “Solicitation”)
for a proposed amendment (the “Proposed Amendment”) to the indenture
(the “Indenture”) governing its outstanding 9.625% Second Lien Senior
Secured Notes Due 2019 (the “Securities”).
The Proposed Amendment to the Indenture would, among other things, amend
the definition of “Consolidated EBITDA” to include in the calculation of
Consolidated EBITDA incremental contributions to Consolidated EBITDA
from (a) certain marketing agreements entered into after the period for
which Consolidated EBITDA is being calculated and before the relevant
date of determination and (b) recoupments SFX expects to receive from
Management Vennootschap BVBA (“M&M”), related to start-up investments
made in connection with a live event in which M&M is a minority partner,
Baxter International Inc. (NYSE:BAX) announced today that it plans to
expand its state-of-the-art manufacturing facility in Opelika, Ala., to
help address the growing global demand for dialyzers, a critical
component used in hemodialysis therapy (HD).
Baxter will invest nearly $300 million in the Opelika site to add
230,000 square feet and several production lines.
By Angela Johnson and Ben Eisen, MarketWatch
NEW YORK (MarketWatch) -- These are the stocks making notable moves on Tuesday:
El Pollo Loco Holdings Inc.(LOCO): A slew of analysts initiated cautious ratings on the company, including Morgan Stanley (underweight) and Baird (neutral). Also read: Analysts chicken out
Elizabeth Arden Inc.(RDEN): The cosmetics and fragrance company reported a wider-than-expected loss in the fiscal fourth quarter and released sales numbers that were below Wall Street estimates.
By Rogerio Jelmayer
SAO PAULO--The board of directors of Brazilian flat-steel maker Companhia Siderurgica Nacional (SID, CSNA3.BR), or CSN, have approved a plan to buy back as much as 292 million Brazilian reais ($127 million) worth of its shares, the company said Tuesday in a statement.
Movado Group, Inc. (NYSE:MOV), invites investors to listen to a
broadcast of the Company's conference call to discuss second quarter
fiscal year 2015 earnings results on Tuesday, August 26, 2014 at 9:00
a.m. Eastern Time.
By William Watts and Barbara Kollmeyer, MarketWatch
NEW YORK (MarketWatch) -- U.S. stock futures hit new premarket highs after a stronger-than-expected jump in July housing starts, adding to upside momentum sparked by a stronger tone in Europe and positive earnings.
Guided Therapeutics, Inc. (OTCBB: GTHP) (OTCQB: GTHP) today announced
that it will begin enrollment this week in a multi-center clinical trial
to expand claims for the LuViva® Advanced Cervical Scan to include
front-line screening for cervical cancer.
Celgene Corporation (NASDAQ:CELG) today announced that results of a
study evaluating the combination of REVLIMID® (lenalidomide) with
rituximab, cyclophosphamide, doxorubicin hydrochloride, vincristine
sulfate and prednisone (R-CHOP) in untreated diffuse large b-cell
lymphoma (DLBCL) were published online ahead of print in the Journal
of Clinical Oncology .
Sign-up for - Clinical Study in the Journal of Clinical Oncology Reports Patients with Diffuse Large B-Cell Lymphoma Receiving Oral REVLIMID with Standard R-CHOP Achieved 98% Overall Response Rate and 80% Complete Response Rate investment picks
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.